DUBLIN--(BUSINESS WIRE)--The "Dupuytren's Disease Market Size, Share & Trends Analysis Report By Type (Diagnosis, Treatment), By Disease Type (Type I, Type II), By End-use (Hospitals, Clinics), By ...
PALO ALTO, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company today announced that ...
PALO ALTO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of ...
The study also showed that if the contracture was corrected to 0˚ to 5˚ of flexion, recurrence rates were significantly lower and required no additional therapy. 12 In addition, most patients maintain ...
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. (NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with ...
PALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the United States Patent and Trademark Office ...
Xiaflex, the drug that treats Peyronie’s disease (curved penises), also treats Dupuytren's contracture (curled fingers). Six months after launching a branded campaign for the former condition, Xiaflex ...
Because of the increased risk of complications and potential for recurrence associated with invasive surgical techniques, there has been renewed interest in simple fasciotomy to treat flexion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback